Guardant Health Earning Date (GH)

USA |NASDAQ |USD

GH Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
Aug 3, 2022 Jun 2022 - - $-0.96
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
Aug 3, 2022 Jun 2022 - - $92.10M

Guardant Health's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 2022.

GH Earnings Date & History Chart

GH Earnings & Revenue Forecast

GH Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 12 $-4.34 $-5.18 $-3.58

GH Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 3 / 1 $-3.34 $-3.34 $-3.19

GH Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 14 $474.71M $453.90M $508.00M

GH Earnings Date & Revenue History

GH Earnings History

|
Show More
Show More

GH Revenue History

|
Show More
Show More

Guardant Health Next Earnings Date & Report

GH Next Earnings Date & Report Preview: Jun 2022 (FQ)

GH's next earnings date is Wednesday, Aug 3, 2022 for the fiscal quarter ending Jun 30, 2022.

Guardant Health Previous Earnings Dates & Reports

GH Previous Earnings Date & Report Recap: Mar 2022 (FQ)

Guardant Health's previous earnings date was May 4, 2022 for its fiscal quarter ended Mar 31, 2022.

GH Previous Earnings Date & Report Recap: Dec 2021 (FY)

Guardant Health's previous annual earnings date was Feb 23, 2022 for its fiscal year ended Dec 31, 2021.

GH's earnings per share (EPS) was $-4.00, beating the consensus analysts forecast of $-4.26 by -6.10% , and lower than the previous year's EPS (Dec 2020) by 55.04%.

Revenues were $373.65M, better than the forecast of $364.70M by 2.45%, and up by 30.32% from previous year's revenue.

The company reported a net income of $-405.67M.

Guardant Health reported a free cash flow of $-284.05M for its fiscal year, compared to $-157.99M a year ago.

The company ended the fiscal year with $1.37B in total debt, an increase of 68.99% compared to the previous year.